Copanlisib plus rituximab vs placebo plus rituximab in patients (pts) with relapsed marginal zone lymphoma (MZL) treated in the phase III CHRONOS-3 trial Meeting Abstract
| Authors: | Özcan, M.; Jin, J.; Szomor, Á.; Panayiotidis, P.; Yoon, D. H.; Tyczynska, A. M.; Mongay Soler, L.; Cao, A.; Hiemeyer, F.; Childs, B. H.; Matasar, M. J.; Zinzani, P. L. |
| Abstract Title: | Copanlisib plus rituximab vs placebo plus rituximab in patients (pts) with relapsed marginal zone lymphoma (MZL) treated in the phase III CHRONOS-3 trial |
| Meeting Title: | ESMO Congress 2021 |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2021 Sep 16-21 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-10-01 |
| Start Page: | S773 |
| End Page: | S774 |
| Language: | English |
| ACCESSION: | WOS:000700527701291 |
| DOI: | 10.1016/j.annonc.2021.08.119 |
| PROVIDER: | Clarivate Analytics Web of Science |
| PROVIDER: | wos |
| Notes: | Meeting Abstract #826O -- Source: Wos |
